Shanghai Medicilon (SHSE:688202) Construction In Progress: ¥94 Mil (As of Mar. 2026)


SHSE:688202 Shanghai Medicilon Inc SHSE:688202
71 GF Score
Price ¥78.50
GF Value ¥45.98
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Medicilon Construction In Progress?

Shanghai Medicilon SHSE:688202 +1.16% 71 Construction In Progress is ¥94 Mil as of Mar. 2026. GuruFocus rates SHSE:688202 with a GF Score™ of 71/100 and a GF Value™ of ¥45.98 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Shanghai Medicilon's quarterly construction in progress increased from Sep. 2025 (¥78 Mil) to Dec. 2025 (¥87 Mil) and increased from Dec. 2025 (¥87 Mil) to Mar. 2026 (¥94 Mil).

Shanghai Medicilon's annual construction in progress increased from Dec. 2023 (¥143 Mil) to Dec. 2024 (¥169 Mil) but then declined from Dec. 2024 (¥169 Mil) to Dec. 2025 (¥87 Mil).

Shanghai Medicilon Construction In Progress Historical Data

* Premium members only.

The historical data trend for Shanghai Medicilon's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Medicilon Construction In Progress Chart

Shanghai Medicilon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 100.62 140.39 142.71 169.19 87.23

Shanghai Medicilon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 174.44 161.28 77.79 87.23 94.16
SHSE:688202
71GF Score
Shanghai Medicilon Inc SHSE:688202
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Medicilon Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥94 Mil mean?
Shanghai Medicilon (SHSE:688202) has a Construction In Progress of ¥94 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Medicilon and its competitors.
Is Shanghai Medicilon's Construction In Progress too high?
Shanghai Medicilon's current Construction In Progress is ¥94 Mil. Overall, Shanghai Medicilon has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Medicilon's Construction In Progress compare to VRTX and REGN?
Shanghai Medicilon's Construction In Progress of ¥94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Shanghai Medicilon and its competitors. Shanghai Medicilon's current Construction In Progress is ¥94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Medicilon stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Medicilon (SHSE:688202) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥45.98, compared to a current price of ¥78.50 — trading 70.7% above its estimated fair value. The current Construction In Progress is ¥94 Mil. Shanghai Medicilon's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Shanghai Medicilon (SHSE:688202), the current Construction In Progress is ¥94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Medicilon (SHSE:688202) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Medicilon stock appears to be overvalued. The current stock price of ¥78.50 is trading 70.7% above its estimated GF Value™ of ¥45.98. GuruFocus considers Shanghai Medicilon to be Significantly Overvalued.

Key valuation signals for SHSE:688202:

  • Construction In Progress: ¥94 Mil
  • GF Value™: ¥45.98 vs. price of ¥78.50 (70.7% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Medicilon Business Description

Address Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
71GF Score

Get the complete analysis for SHSE:688202

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥78.50
Price
¥45.98
GF Value